rs11771941

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.2383+4454G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.367 in 152,050 control chromosomes in the GnomAD database, including 12,200 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.37 ( 12200 hom., cov: 32)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.44

Publications

3 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.49 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNTNAP2NM_014141.6 linkc.2383+4454G>A intron_variant Intron 15 of 23 ENST00000361727.8 NP_054860.1 Q9UHC6-1A0A090N7T7B2RCH4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNTNAP2ENST00000361727.8 linkc.2383+4454G>A intron_variant Intron 15 of 23 1 NM_014141.6 ENSP00000354778.3 Q9UHC6-1
CNTNAP2ENST00000627772.2 linkn.556+4454G>A intron_variant Intron 4 of 12 2
CNTNAP2ENST00000636870.1 linkn.2245+4454G>A intron_variant Intron 13 of 21 5
CNTNAP2ENST00000637825.1 linkn.1866+4454G>A intron_variant Intron 12 of 13 5

Frequencies

GnomAD3 genomes
AF:
0.368
AC:
55853
AN:
151932
Hom.:
12206
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.146
Gnomad AMI
AF:
0.605
Gnomad AMR
AF:
0.339
Gnomad ASJ
AF:
0.622
Gnomad EAS
AF:
0.162
Gnomad SAS
AF:
0.506
Gnomad FIN
AF:
0.373
Gnomad MID
AF:
0.631
Gnomad NFE
AF:
0.495
Gnomad OTH
AF:
0.431
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.367
AC:
55847
AN:
152050
Hom.:
12200
Cov.:
32
AF XY:
0.364
AC XY:
27058
AN XY:
74318
show subpopulations
African (AFR)
AF:
0.146
AC:
6043
AN:
41496
American (AMR)
AF:
0.338
AC:
5160
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.622
AC:
2158
AN:
3470
East Asian (EAS)
AF:
0.162
AC:
835
AN:
5160
South Asian (SAS)
AF:
0.506
AC:
2438
AN:
4814
European-Finnish (FIN)
AF:
0.373
AC:
3944
AN:
10574
Middle Eastern (MID)
AF:
0.623
AC:
182
AN:
292
European-Non Finnish (NFE)
AF:
0.495
AC:
33626
AN:
67958
Other (OTH)
AF:
0.433
AC:
913
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1616
3232
4848
6464
8080
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
550
1100
1650
2200
2750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.464
Hom.:
32255
Bravo
AF:
0.351
Asia WGS
AF:
0.329
AC:
1143
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
4.8
DANN
Benign
0.78
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11771941; hg19: chr7-147679535; API